Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET Company Participants Juli Miller - IR Adrian Rawcliffe - CEO Helen Tayton-Martin - Co-Founder and Chief Business Officer Elliot Norry - Senior VP and Chief Medical Officer John Lunger - Chief Patient Supply Officer Conference Call Participants Tony Butler - ROTH Capital Marc Frahm - Cowen and Company Kelsey Goodwin - Guggenheim Jonathan Chang - SVB Leerink Mara Goldstein - Mizuho Operator Good day and thank ...